[Osteoclastic activation factors].
de Vernejoul
M C
MC
INSERM U18. Centre Viggo Petersen, Hôpital lariboisière, Paris.
Orcel
P
P
D001862:Bone Resorption / Q000503:physiopathology*; D004815:Epidermal Growth Factor / Q000502:physiology; D006801:Humans; D007375:Interleukin-1 / Q000502:physiology; D008222:Lymphokines / Q000502:physiology; D010982:Platelet-Derived Growth Factor / Q000502:physiology; D011453:Prostaglandins / Q000502:physiology; D015291:Transforming Growth Factors / Q000502:physiology; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D007375:Interleukin-1; D008222:Lymphokines; D010982:Platelet-Derived Growth Factor; D011453:Prostaglandins; D014409:Tumor Necrosis Factor-alpha; D004815:Epidermal Growth Factor; C008718:osteoclast activating factor; D015291:Transforming Growth Factors
Facteurs d'activation ostéoclastique.